Market Overview:
The global cancer biologics market is projected to be valued at US$ 94.5 Bn in 2022, and is anticipated to grow at a CAGR of 7.7% over the forecast period of 2023-2031. Cancer biologics refer to targeted therapies that use substances derived from living organisms to treat various types of cancers. These biologics offer several advantages over conventional chemotherapy, such as enhanced efficacy, reduced side effects, and personalized ... Read more
